0

Close
 
Upcoming Allied Market Research
2023
Cbd Nutraceuticals Market

CBD Nutraceuticals Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

LS : Pharmaceuticals
Report Code: A08082
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cbd Nutraceuticals Market

Request Now !

Nutraceuticals are super foods or fortified foods which helps with supply of essentials nutrients to the body along with preventing or treating a disease. Cannabidiol (CBD) is a constituent that belongs to a family of chemical compounds called cannabinoids). It is an important constituent of marijuana in medical field. CBD is a mixture of various chemical compounds which have clinical significance in treatment against a variety of diseases. CBD is also attributed to be effective against various health problems and ailments like cancer, anxiety and depression and has added advantages such as pain relief, boosting cognitive abilities, anti-inflammatory properties among others along with minimum side effects. Pertaining to its wide application against variety of diseases and immense health benefits have attracted the nutraceutical industries to integrate this constituent in their current product portfolio. There has been a dramatic rise edibles or super foods containing CBD. For instance, edibles like cliché special brownie, beverages, cookies, candy and even dried meat containing CBD as one of the ingredients.

COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to novel coronavirus
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to CBD has been reduced and this segment have to face negligence subsequently

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Due to recent studies and subsequent research of various CBD substances brought to notice the importance of CBD medical industry. In 2017, the National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies. According to a report published by World Health Organization, CBD shows no significant results indicative of any abuse or dependence potential. As of now, there is no significant evidence of side effects associated with the use of CBD. Consumer preference inclining towards plant-based organic supplementary products, increasing awareness and knowledge regarding CBD and its health benefits with least after effects and legalization of CBD based products by regulatory authorities are the key driving factors that will propel the growth of the CBD nutraceuticals market in coming future. The passing of the Farm Bill of 2018 had been beneficial for hemp farmers as they it gave them eligibility to cultivate hemp, resulting in the immense supply of hemp-based CBD products available as nutraceuticals in the market. These nutraceuticals are gaining immense popularity as they’re free of intoxication and furthermore the demand for variety of hemp-based proteins as it contains easily digestible twenty amino acids. This rising demand is seen majorly in fitness enthusiasts, body builders, athletes and specifically in the vegan population. In addition, the availability of CBD tinctures, soft gel capsules have made a significant progress as they are travel friendly and convenient to carry. These factors would surge the demand for CBD nutraceuticals in the market providing immense opportunity to grow in potential and less explored markets in Asia-Pacific region.

However, due to presence of alternative plant-based nutraceuticals like raspberry ketones, garcinia cambogia, turmeric and Echinacea, prohibition for the use of CBD in some countries, the strict regulations regarding use of CBD-based products has been obstructing factors in the growth of CBD nutraceuticals market.

Recent developments and competition in the market to fuel the growth

Investments in R&D activities related to CBD Nutraceuticals have led to various developments in the nutraceutical market. Nutraceutical companies are coming up with various forms of these nutraceuticals that contain CBD. For instance, Australian biopharmaceutical company, MGC Pharmaceuticals entered into a strategic alliance with Yu-shop Global, a Chinese e-commerce platform for gaining entry in the Chinese CBD nutraceuticals market. Nutraceutical products like CBD capsules, water-soluble CBD solution, and hemp powder were launched in China by MGC Pharma. Aphria Inc. entered the German market by launched its first cannabidiol based nutraceutical product portfolio named CannRelief to enter the German market in April 2019. Various major players are adopting the strategy of collaborating with distribution service providers for better reach towards the customers. In September 2019, Charlotte's Web and The Vitamin Shoppe signed an agreement for selling of CBD gummies across 738 retail stores in U.S. Similarly CV Sciences, Inc. joined hands with The Vitamin Shoppe for better distribution of their products and began selling its products across 383 stores in U.S. thus, the growing competition is expected to boost market growth.

North America Emerges as the Largest Market for CBD Nutraceuticals

Legalization of marijuana countries like the United States, increasing usage due to rising awareness of the health benefits of CBD-based nutraceuticals, North American region is predicted to have immense growth with highest market share in the global market. The presence of industry players in the region is also having a promising impact on the CBD nutraceuticals market growth. Furthermore, increasing population of health-conscious consumers, the heavy funding for R&D activities and well-developed healthcare infrastructure are fueling the market growth for CBD nutraceuticals market.

Key benefits of the report:

  • This study presents the analytical depiction of the global CBD nutraceuticals industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global CBD nutraceuticals market share.
  • The current market is quantitatively analysed to highlight the global CBD nutraceuticals market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global CBD nutraceuticals market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the CBD Nutraceuticals Market research report:

  • Who are the leading market players active in the CBD nutraceuticals market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

 CBD Nutraceuticals Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Product
  • CBD tinctures
  • Capsules & Soft gels
  • CBD-based protein
  • CBD Gummies
  • Others
By Application
  • Wellness
  • Workout supplements
  • Edibles and fortified foods
  • Others
By Distribution channels
  • Retail stores
  • Pharmacies
  • E-commerce portals
  • Others
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)
Key Market Players Foria Wellness, Garden of Life, Diamond CBD, Charlotte's Web, Elixinol, Bluebird Botanicals., Green Roads, Medical Marijuana, Inc., CV Sciences, Inc., Irwin Naturals
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CBD NUTRACEUTICALS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. CBD Tinctures

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Capsules Soft Gels

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. CBD-based Protein

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. CBD Gummies

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: CBD NUTRACEUTICALS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Wellness

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Workout Supplements

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Edibles And Fortified Foods

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: CBD NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNELS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Distribution Channels

    • 6.2. Retail Stores

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Pharmacies

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. E-commerce Portals

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: CBD NUTRACEUTICALS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Distribution Channels

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Cbd Nutraceuticals Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Distribution Channels

      • 7.2.7. Canada Cbd Nutraceuticals Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Distribution Channels

      • 7.2.8. Mexico Cbd Nutraceuticals Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Distribution Channels

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Distribution Channels

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Cbd Nutraceuticals Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Distribution Channels

      • 7.3.7. Germany Cbd Nutraceuticals Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Distribution Channels

      • 7.3.8. Italy Cbd Nutraceuticals Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Distribution Channels

      • 7.3.9. Spain Cbd Nutraceuticals Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Distribution Channels

      • 7.3.10. UK Cbd Nutraceuticals Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Distribution Channels

      • 7.3.11. Russia Cbd Nutraceuticals Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Distribution Channels

      • 7.3.12. Rest Of Europe Cbd Nutraceuticals Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Distribution Channels

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Distribution Channels

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Cbd Nutraceuticals Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Distribution Channels

      • 7.4.7. Japan Cbd Nutraceuticals Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Distribution Channels

      • 7.4.8. India Cbd Nutraceuticals Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Distribution Channels

      • 7.4.9. South Korea Cbd Nutraceuticals Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Distribution Channels

      • 7.4.10. Australia Cbd Nutraceuticals Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Distribution Channels

      • 7.4.11. Thailand Cbd Nutraceuticals Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Distribution Channels

      • 7.4.12. Malaysia Cbd Nutraceuticals Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Distribution Channels

      • 7.4.13. Indonesia Cbd Nutraceuticals Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Distribution Channels

      • 7.4.14. Rest of Asia Pacific Cbd Nutraceuticals Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Distribution Channels

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Distribution Channels

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Cbd Nutraceuticals Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Distribution Channels

      • 7.5.7. South Africa Cbd Nutraceuticals Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Distribution Channels

      • 7.5.8. Saudi Arabia Cbd Nutraceuticals Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Distribution Channels

      • 7.5.9. UAE Cbd Nutraceuticals Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Distribution Channels

      • 7.5.10. Argentina Cbd Nutraceuticals Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Distribution Channels

      • 7.5.11. Rest of LAMEA Cbd Nutraceuticals Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Distribution Channels

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Charlotte's Web

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Elixinol

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Medical Marijuana, Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. CV Sciences, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Irwin Naturals

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Diamond CBD

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Green Roads

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Foria Wellness

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Garden Of Life

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Bluebird Botanicals.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CBD NUTRACEUTICALS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CBD NUTRACEUTICALS MARKET FOR CBD TINCTURES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CBD NUTRACEUTICALS MARKET FOR CAPSULES SOFT GELS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CBD NUTRACEUTICALS MARKET FOR CBD-BASED PROTEIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CBD NUTRACEUTICALS MARKET FOR CBD GUMMIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CBD NUTRACEUTICALS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CBD NUTRACEUTICALS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CBD NUTRACEUTICALS MARKET FOR WELLNESS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL CBD NUTRACEUTICALS MARKET FOR WORKOUT SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CBD NUTRACEUTICALS MARKET FOR EDIBLES AND FORTIFIED FOODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL CBD NUTRACEUTICALS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL CBD NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL CBD NUTRACEUTICALS MARKET FOR RETAIL STORES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL CBD NUTRACEUTICALS MARKET FOR PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL CBD NUTRACEUTICALS MARKET FOR E-COMMERCE PORTALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL CBD NUTRACEUTICALS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL CBD NUTRACEUTICALS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA CBD NUTRACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 22. U.S. CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. U.S. CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. U.S. CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 25. CANADA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. CANADA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. CANADA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE CBD NUTRACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 41. ITALY CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. ITALY CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. ITALY CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 47. UK CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. UK CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. UK CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. RUSSIA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. REST OF EUROPE CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC CBD NUTRACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. ASIA-PACIFIC CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 60. CHINA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 61. CHINA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. CHINA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. JAPAN CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 66. INDIA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. INDIA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. INDIA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. AUSTRALIA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. THAILAND CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. MALAYSIA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. INDONESIA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA CBD NUTRACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 90. LAMEA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. BRAZIL CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. SAUDI ARABIA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 100. UAE CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. UAE CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. UAE CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 105. ARGENTINA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA CBD NUTRACEUTICALS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA CBD NUTRACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. REST OF LAMEA CBD NUTRACEUTICALS, BY DISTRIBUTION CHANNELS, 2022-2032 ($MILLION)
  • TABLE 109. CHARLOTTE'S WEB: KEY EXECUTIVES
  • TABLE 110. CHARLOTTE'S WEB: COMPANY SNAPSHOT
  • TABLE 111. CHARLOTTE'S WEB: OPERATING SEGMENTS
  • TABLE 112. CHARLOTTE'S WEB: PRODUCT PORTFOLIO
  • TABLE 113. CHARLOTTE'S WEB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. ELIXINOL: KEY EXECUTIVES
  • TABLE 115. ELIXINOL: COMPANY SNAPSHOT
  • TABLE 116. ELIXINOL: OPERATING SEGMENTS
  • TABLE 117. ELIXINOL: PRODUCT PORTFOLIO
  • TABLE 118. ELIXINOL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. MEDICAL MARIJUANA, INC.: KEY EXECUTIVES
  • TABLE 120. MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT
  • TABLE 121. MEDICAL MARIJUANA, INC.: OPERATING SEGMENTS
  • TABLE 122. MEDICAL MARIJUANA, INC.: PRODUCT PORTFOLIO
  • TABLE 123. MEDICAL MARIJUANA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. CV SCIENCES, INC.: KEY EXECUTIVES
  • TABLE 125. CV SCIENCES, INC.: COMPANY SNAPSHOT
  • TABLE 126. CV SCIENCES, INC.: OPERATING SEGMENTS
  • TABLE 127. CV SCIENCES, INC.: PRODUCT PORTFOLIO
  • TABLE 128. CV SCIENCES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. IRWIN NATURALS: KEY EXECUTIVES
  • TABLE 130. IRWIN NATURALS: COMPANY SNAPSHOT
  • TABLE 131. IRWIN NATURALS: OPERATING SEGMENTS
  • TABLE 132. IRWIN NATURALS: PRODUCT PORTFOLIO
  • TABLE 133. IRWIN NATURALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. DIAMOND CBD: KEY EXECUTIVES
  • TABLE 135. DIAMOND CBD: COMPANY SNAPSHOT
  • TABLE 136. DIAMOND CBD: OPERATING SEGMENTS
  • TABLE 137. DIAMOND CBD: PRODUCT PORTFOLIO
  • TABLE 138. DIAMOND CBD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. GREEN ROADS: KEY EXECUTIVES
  • TABLE 140. GREEN ROADS: COMPANY SNAPSHOT
  • TABLE 141. GREEN ROADS: OPERATING SEGMENTS
  • TABLE 142. GREEN ROADS: PRODUCT PORTFOLIO
  • TABLE 143. GREEN ROADS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. FORIA WELLNESS: KEY EXECUTIVES
  • TABLE 145. FORIA WELLNESS: COMPANY SNAPSHOT
  • TABLE 146. FORIA WELLNESS: OPERATING SEGMENTS
  • TABLE 147. FORIA WELLNESS: PRODUCT PORTFOLIO
  • TABLE 148. FORIA WELLNESS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. GARDEN OF LIFE: KEY EXECUTIVES
  • TABLE 150. GARDEN OF LIFE: COMPANY SNAPSHOT
  • TABLE 151. GARDEN OF LIFE: OPERATING SEGMENTS
  • TABLE 152. GARDEN OF LIFE: PRODUCT PORTFOLIO
  • TABLE 153. GARDEN OF LIFE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. BLUEBIRD BOTANICALS.: KEY EXECUTIVES
  • TABLE 155. BLUEBIRD BOTANICALS.: COMPANY SNAPSHOT
  • TABLE 156. BLUEBIRD BOTANICALS.: OPERATING SEGMENTS
  • TABLE 157. BLUEBIRD BOTANICALS.: PRODUCT PORTFOLIO
  • TABLE 158. BLUEBIRD BOTANICALS.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CBD NUTRACEUTICALS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CBD NUTRACEUTICALS MARKET
  • FIGURE 3. SEGMENTATION CBD NUTRACEUTICALS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CBD NUTRACEUTICALS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCBD NUTRACEUTICALS MARKET
  • FIGURE 11. CBD NUTRACEUTICALS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. CBD NUTRACEUTICALS MARKET FOR CBD TINCTURES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CBD NUTRACEUTICALS MARKET FOR CAPSULES SOFT GELS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CBD NUTRACEUTICALS MARKET FOR CBD-BASED PROTEIN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. CBD NUTRACEUTICALS MARKET FOR CBD GUMMIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CBD NUTRACEUTICALS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. CBD NUTRACEUTICALS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. CBD NUTRACEUTICALS MARKET FOR WELLNESS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. CBD NUTRACEUTICALS MARKET FOR WORKOUT SUPPLEMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. CBD NUTRACEUTICALS MARKET FOR EDIBLES AND FORTIFIED FOODS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. CBD NUTRACEUTICALS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. CBD NUTRACEUTICALS MARKET SEGMENTATION, BY BY DISTRIBUTION CHANNELS
  • FIGURE 23. CBD NUTRACEUTICALS MARKET FOR RETAIL STORES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. CBD NUTRACEUTICALS MARKET FOR PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. CBD NUTRACEUTICALS MARKET FOR E-COMMERCE PORTALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. CBD NUTRACEUTICALS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 31. COMPETITIVE DASHBOARD
  • FIGURE 32. COMPETITIVE HEATMAP: CBD NUTRACEUTICALS MARKET
  • FIGURE 33. Top player positioning, 2022
  • FIGURE 34. CHARLOTTE'S WEB: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. CHARLOTTE'S WEB: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. CHARLOTTE'S WEB: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. ELIXINOL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. ELIXINOL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. ELIXINOL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. MEDICAL MARIJUANA, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. MEDICAL MARIJUANA, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. MEDICAL MARIJUANA, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. CV SCIENCES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. CV SCIENCES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. CV SCIENCES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. IRWIN NATURALS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. IRWIN NATURALS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. IRWIN NATURALS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. DIAMOND CBD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. DIAMOND CBD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. DIAMOND CBD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. GREEN ROADS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. GREEN ROADS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. GREEN ROADS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. FORIA WELLNESS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. FORIA WELLNESS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. FORIA WELLNESS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. GARDEN OF LIFE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. GARDEN OF LIFE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. GARDEN OF LIFE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. BLUEBIRD BOTANICALS.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. BLUEBIRD BOTANICALS.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. BLUEBIRD BOTANICALS.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Cbd Nutraceuticals Market

Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers